These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32662066)

  • 1. The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature.
    Noda C; Williams GA; Foltz G; Kim H; Sanford DE; Hammill CW; Fields RC
    J Surg Oncol; 2020 Nov; 122(6):1114-1121. PubMed ID: 32662066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes comparing surgery to embolization-ablation for treatment of solitary HCC<7 cm.
    Elnekave E; Erinjeri JP; Brown KT; Thornton RH; Petre EN; Maybody M; Maluccio MA; Hsu M; Sofocleous CT; Getrajdman GI; Brody LA; Solomon SB; Alago W; Fong Y; Jarnagin WR; Covey AM
    Ann Surg Oncol; 2013 Sep; 20(9):2881-6. PubMed ID: 23563960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing trends in long-term outcomes after hepatic resection for hepatocellular carcinoma: A 30-year, single-center experience.
    Yamamoto Y; Ikoma H; Morimura R; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
    Anticancer Res; 2013 Nov; 33(11):5097-105. PubMed ID: 24222155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion.
    Spreafico C; Sposito C; Vaiani M; Cascella T; Bhoori S; Morosi C; Lanocita R; Romito R; Chiesa C; Maccauro M; Marchianò A; Mazzaferro V
    J Hepatol; 2018 Apr; 68(4):724-732. PubMed ID: 29331342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yttrium-90 Radioembolization as a Salvage Treatment following Chemoembolization for Hepatocellular Carcinoma.
    Johnson GE; Monsky WL; Valji K; Hippe DS; Padia SA
    J Vasc Interv Radiol; 2016 Aug; 27(8):1123-9. PubMed ID: 27321889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and safety of liver transplantation or resection after transarterial radioembolization with Yttrium-90 for unresectable hepatocellular carcinoma.
    Labgaa I; Tabrizian P; Titano J; Kim E; Thung SN; Florman S; Schwartz M; Melloul E
    HPB (Oxford); 2019 Nov; 21(11):1497-1504. PubMed ID: 31005494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C; Lazarev S; Ru M; Kim E; Fischman A; Moshier E; Rosenzweig K; Buckstein M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):968-976. PubMed ID: 31536781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.
    McGee HM; King MJ; Özbek U; Olson A; Kim E; Fischman AM; Schwartz M; Rosenzweig KE; Buckstein M
    Am J Clin Oncol; 2019 Apr; 42(4):367-374. PubMed ID: 30724782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma.
    Gabr A; Abouchaleh N; Ali R; Baker T; Caicedo J; Katariya N; Abecassis M; Riaz A; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2018 Nov; 29(11):1502-1510.e1. PubMed ID: 30268638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis.
    Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C
    Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma.
    Kim Y; Lee HA; Lee JS; Jeon MY; Kim BK; Park JY; Kim DY; Ahn SH; Um SH; Seo YS; Kim SU
    Cancer Invest; 2021 Mar; 39(3):274-283. PubMed ID: 33356630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.
    Kow AW; Kwon CH; Song S; Shin M; Kim JM; Joh JW
    Ann Surg Oncol; 2012 Jul; 19(7):2246-55. PubMed ID: 22402812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma.
    Moreno-Luna LE; Yang JD; Sanchez W; Paz-Fumagalli R; Harnois DM; Mettler TA; Gansen DN; de Groen PC; Lazaridis KN; Narayanan Menon KV; Larusso NF; Alberts SR; Gores GJ; Fleming CJ; Slettedahl SW; Harmsen WS; Therneau TM; Wiseman GA; Andrews JC; Roberts LR
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):714-23. PubMed ID: 23093355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yttrium-90 radioembolization vs sorafenib for intermediate-locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis.
    Gramenzi A; Golfieri R; Mosconi C; Cappelli A; Granito A; Cucchetti A; Marinelli S; Pettinato C; Erroi V; Fiumana S; Bolondi L; Bernardi M; Trevisani F;
    Liver Int; 2015 Mar; 35(3):1036-47. PubMed ID: 24750853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization for Hepatocellular Carcinoma: A Nationwide 10-Year Experience.
    Tohme S; Bou Samra P; Kaltenmeier C; Chidi AP; Varley PR; Tsung A
    J Vasc Interv Radiol; 2018 Jul; 29(7):912-919.e2. PubMed ID: 29843996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Song JE; Jung KS; Kim DY; Song K; Won JY; Lee HW; Kim BK; Kim SU; Park JY; Ahn SH; Seong J; Han KH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):396-406. PubMed ID: 28871990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Care and Outcomes of Definitive External Beam Radiotherapy and Radioembolization for Localized Hepatocellular Carcinoma: A Propensity Score-adjusted Analysis.
    Bitterman DS; Sanford NN; Niemierko A; Mahal BA; Qadan M; Ganguli S; Blaszkowsky LS; Zhu AX; Hong TS; Devlin PM; Goyal L; Wo JY
    Am J Clin Oncol; 2019 Jul; 42(7):564-572. PubMed ID: 31166209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of transarterial chemoembolization induced complications on outcomes after liver transplantation: A propensity-matched study.
    Boteon APCDS; Boteon YL; Vinuela EF; Derosas C; Mergental H; Isaac JR; Muiesan P; Mehzard H; Ma YT; Shah T; Mirza DF; Perera MTPR
    Clin Transplant; 2018 May; 32(5):e13255. PubMed ID: 29637619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.